Fatal mistake: Argentina medtech: ANMAT medical device registration took 24-36 months (Class III devices). Peso devaluation 2019-2022 (120%+) made USD-component medical device manufacturing unaffordable. PAMI and IOMA (major public health insurers) required 5-year local track record for reimbursement. Surgical robotics import duties 40%+ made competitive pricing impossible.
Evaluating only MedTechAR’s profile at its peak — without knowing the outcome — the model ranked Macro / political as the #1 likely cause. That’s exactly how it died.
Key Events Timeline
FOUNDING
CRISIS
SHUTDOWN
Full Analysis
Free · no account needed
Documented cause
MedTechAR built diagnostic imaging AI. ANMAT 36-month registration. Peso -120%: USD components 3x more expensive. PAMI track record requirement. Import duties 40%+. Market exit.
Lesson
“Argentina medtech must register devices in Brazil or Chile first (both have faster timelines and stable currencies) then use those registrations to accelerate ANMAT — regional registration precedent reduces ANMAT review time.”
Failure anatomy
Collapse type
Market Exit
📉 MEDIUM
Hype cycle
None
Moat type
Technology
Fatal mistake
Argentina medtech: ANMAT medical device registration took 24-36 months (Class III devices). Peso devaluation 2019-2022 (120%+) made USD-component medical device manufacturing unaffordable. PAMI and IOMA (major public health insurers) required 5-year local track record for reimbursement. Surgical robotics import duties 40%+ made competitive pricing impossible.
// engine intelligence on MedTechAR
Tier 1 · instant unlock🔒 free account
Loading engine analysis…
Tier 2 · the productAnalyst · €149/mo
What you see retrospectively on MedTechAR, applied predictively to your companies:
→Cross-reference this pattern against your live portfolio
→Alerts when a company you track starts matching this profile